Volkl, Albert A.
Moore, Kenneth Todd
Haskell, Lloyd
Barnathan, Elliot S.
Funding for this research was provided by:
Janssen Scientific Affairs, LLC
Article History
Accepted: 22 March 2023
First Online: 28 April 2023
Declarations
:
: Medical writing support was provided by Michelle McDermott, PharmD, of Lumanity Communications Inc., and was funded by Janssen Scientific Affairs, LLC.
: Albert A. Volkl, Kenneth Todd Moore, Lloyd Haskell, and Elliot S. Barnathan are employees of Janssen and may hold stock in Johnson & Johnson.
: AAV, KTM, LH, and ESB contributed to the study conceptualization, data interpretation, manuscript writing, and reviewing. All authors approved the final version of this manuscript for submission.
: The data sharing policy of Janssen Pharmaceutical Companies of Johnson & Johnson is available at ExternalRef removed. As noted on this site, requests for access to the study data can be submitted through the Yale Open Data Access [YODA] Project site at ExternalRef removed.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.